TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 27 filers reported holding TRINITY BIOTECH PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $581 | -42.0% | 1,353,898 | -0.7% | 0.00% | -50.0% |
Q3 2023 | $1,002 | -23.3% | 1,363,198 | -0.7% | 0.00% | 0.0% |
Q2 2023 | $1,306 | +0.9% | 1,372,798 | -0.3% | 0.00% | 0.0% |
Q1 2023 | $1,294 | -6.2% | 1,376,898 | -1.2% | 0.00% | 0.0% |
Q4 2022 | $1,380 | -99.9% | 1,393,438 | -3.1% | 0.00% | 0.0% |
Q3 2022 | $1,540,000 | -16.4% | 1,438,238 | -4.3% | 0.00% | 0.0% |
Q2 2022 | $1,842,000 | +18.3% | 1,503,336 | +2.4% | 0.00% | 0.0% |
Q1 2022 | $1,557,000 | -30.6% | 1,468,436 | -6.4% | 0.00% | -33.3% |
Q4 2021 | $2,243,000 | -40.6% | 1,568,555 | -10.2% | 0.00% | -40.0% |
Q3 2021 | $3,773,000 | -30.6% | 1,746,841 | -5.6% | 0.01% | -28.6% |
Q2 2021 | $5,439,000 | -21.6% | 1,850,082 | +0.3% | 0.01% | -22.2% |
Q1 2021 | $6,937,000 | -4.5% | 1,844,963 | -3.2% | 0.01% | +12.5% |
Q4 2020 | $7,265,000 | +114.6% | 1,906,806 | +13.8% | 0.01% | +166.7% |
Q3 2020 | $3,386,000 | -1.6% | 1,676,270 | +6.2% | 0.00% | 0.0% |
Q2 2020 | $3,440,000 | +257.6% | 1,578,110 | +80.5% | 0.00% | +200.0% |
Q1 2020 | $962,000 | +35.5% | 874,225 | +27.2% | 0.00% | 0.0% |
Q4 2019 | $710,000 | -13.7% | 687,161 | +1.0% | 0.00% | 0.0% |
Q3 2019 | $823,000 | -27.2% | 680,370 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $1,131,000 | -35.3% | 685,496 | +11.7% | 0.00% | -50.0% |
Q1 2019 | $1,749,000 | +28.2% | 613,811 | +3.0% | 0.00% | +100.0% |
Q4 2018 | $1,364,000 | -42.1% | 595,711 | +1.1% | 0.00% | -50.0% |
Q3 2018 | $2,357,000 | -53.9% | 589,209 | -41.6% | 0.00% | -33.3% |
Q2 2018 | $5,113,000 | +115.4% | 1,008,915 | +118.8% | 0.00% | 0.0% |
Q1 2018 | $2,374,000 | +16.7% | 461,050 | +15.6% | 0.00% | +50.0% |
Q4 2017 | $2,034,000 | +30.2% | 398,850 | +43.2% | 0.00% | 0.0% |
Q3 2017 | $1,562,000 | +12.7% | 278,450 | +20.6% | 0.00% | 0.0% |
Q2 2017 | $1,386,000 | +41.3% | 230,950 | +40.3% | 0.00% | +100.0% |
Q1 2017 | $981,000 | +4.3% | 164,650 | +21.1% | 0.00% | 0.0% |
Q4 2016 | $941,000 | -70.0% | 135,950 | -42.7% | 0.00% | -83.3% |
Q3 2016 | $3,139,000 | +70.3% | 237,450 | +46.1% | 0.01% | +50.0% |
Q2 2016 | $1,843,000 | -18.6% | 162,550 | -16.3% | 0.00% | 0.0% |
Q1 2016 | $2,264,000 | -4.7% | 194,150 | -3.9% | 0.00% | -20.0% |
Q4 2015 | $2,376,000 | -5.3% | 202,065 | -7.8% | 0.01% | -16.7% |
Q3 2015 | $2,508,000 | -48.3% | 219,196 | -18.3% | 0.01% | -45.5% |
Q2 2015 | $4,847,000 | +2.0% | 268,363 | +8.7% | 0.01% | +10.0% |
Q1 2015 | $4,754,000 | -16.4% | 246,954 | -24.0% | 0.01% | -28.6% |
Q4 2014 | $5,690,000 | -27.6% | 324,929 | -24.5% | 0.01% | -36.4% |
Q3 2014 | $7,859,000 | -24.3% | 430,150 | -4.6% | 0.02% | -8.3% |
Q2 2014 | $10,388,000 | -4.8% | 451,050 | +0.2% | 0.02% | -7.7% |
Q1 2014 | $10,910,000 | -10.6% | 450,272 | -7.2% | 0.03% | -10.3% |
Q4 2013 | $12,198,000 | +10.3% | 485,221 | -4.5% | 0.03% | +7.4% |
Q3 2013 | $11,058,000 | +62.0% | 508,200 | +25.5% | 0.03% | +50.0% |
Q2 2013 | $6,825,000 | – | 405,050 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 815,041 | $15,690,000 | 4.96% |
Lyon Street Capital, LLC | 570,387 | $10,980,000 | 4.73% |
Centaur Capital | 135,000 | $2,599,000 | 3.61% |
GOLDMAN CAPITAL MANAGEMENT INC | 309,690 | $5,962,000 | 3.48% |
Paradice Investment Management LLC | 584,024 | $11,242,000 | 2.36% |
RK Capital | 601,672 | $11,582,000 | 2.31% |
Park West Asset Management LLC | 673,079 | $12,957,000 | 1.89% |
KEANE CAPITAL MANAGEMENT INC | 95,259 | $1,834,000 | 1.79% |
Adirondack Research & Management Inc. | 227,052 | $4,371,000 | 1.70% |
Benchmark Capital Advisors | 92,441 | $1,779,000 | 1.17% |